References
Lloyd SE, Gunther W, Pearce SH, Thomson A, Bianchi ML, Bosio M, Craig IW, Fisher SE, Scheinman SJ, Wrong O, Jentsch TJ, Thakker RV (1997) Characterisation of renal chloride channel, CLCN5, mutations in hypercalciuric nephrolithiasis (kidney stone) disorders. Hum Mol Genet 8:1233–1239
Muller-Suur R, Gutsche HU (1995) Tubular reabsorption of technetium-99 m-DMSA. J Nucl Med 36(9):1654–1658
Gambaro G, Vezzoli G, Casari G, Rampoldi L, D'Angelo A, Borghi L (2004) Genetics of hypercalciuria and calcium nephrolithiasis: from the rare monogenic to the common polygenic forms. Am J Kidney Dis 44:963–986
Dent CE, Friedman M (1964) Hypercalciuric rickets associated with renal tubular damage. Arch Dis Child 39:240–249
Wrong OM, Norden AGW, Feest TG (1994) Dent's disease: a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance. Quart J Med 87:473–493
Ludwig M, Utsch B, Monnens L (2006) Recent advances in understanding the clinical and genetic heterogeneity of Dent’s disease. Nephrol Dial Transplant 21:2708–2717
Lee BH, Lee SH, Chol HJ, Kang HG, Oh SW, Lee DS, Ha HS, Choi Y, Cheong HI (2006) Decreased renal uptake of 99mTc-DMSA in patients with tubular proteinuria. Pediatr Nephrol 24:2211–2216
Suzuki S, Suzuki J, Kume K, Yoshida K, Suyama H, Kawasaki Y, Nozawa R, Suzuki H, Fujiki T, Kamiyama S, Suzuki A (1999) Poor renal accumulation of 99mTc-DMSA in idiopathic tubular proteinuria. Nephron 81:49–54
Ludwig M, Utsch B, Balluch B, Fruend S, Kuwertz-Broeking E, Boekenkamp A (2006) Hypercalciuria in patients with CLCN5 mutations. Pediatr Nephrol 21:1241–1250
Smith AJ, Reed A, Loh NY, Thakker RV, Lippiat JD (2009) Characterization of Dent's disease mutations of CLC-5 reveals a correlation between functional and cell biological consequences and protein structure. Am J Physiol Renal Physiol 296:F390–F397
Devuyst O, Jouret F, Auzanneau C, Courtoy PJ (2005) Chloride channels and endocytosis: new insights from Dent’s disease and CIC-5 knockout mice. Nephron Physiol 99:69–73
Raja KA, Schurman S, D'mello RG, Blowey D, Goodyer P, Van Why S, Ploutz-Snyder RJ, Asplin J, Scheinman SJ (2002) Responsiveness of hypercalciuria to thiazide in Dent’s disease. J Am Soc Nephrol 13:2938–2944
Blanchard A, Vargas-Poussou R, Peyrard S, Mogenet A, Baudouin V, Boudailliez B, Charbit M, Deschesnes G, Ezzhair N, Loirat C, Macher MA, Niaudet P, Azizi M (2008) Effect of hydrochlorothiazide on urinary calcium excretion in dent disease: an uncontrolled trial. Am J Kidney Dis 52:1084–1095
Cebotaru V, Kaul S, Devuyst O, Cai H, Racusen L, Guggino WB, Guggino SE (2005) High citrate diet delays progression of renal insufficiency in the CIC-5 knockout mouse model of Dent’s disease. Kidney Int 68:642–652
Levtchenko E, Blom H, Wilmer M, van den Heuvel L, Monnens L (2003) ACE inhibitor enalapril diminishes albuminuria in patients with cystinosis. Clin Nephrol 60:386–389
Caglar M, Yaris N, Akyuz C (2001) The utility of 99mTc-DMSA and Tc99-EC scintigraphy for early diagnosis of ifosfamide induced nephrotoxicity. Nuc Med Comm 22:1325–1332
Acknowledgements
We would like to thank the staff at the Human Genetics Dept, University Medical Centre, Nijmegen, Netherlands, for undertaking the genetic analysis.
Author information
Authors and Affiliations
Corresponding author
Additional information
This refers to the article that can be found at doi:10.1007/s00467-011-1912-z.
Answer: Tubulopathy secondary to Dent disease.
Rights and permissions
About this article
Cite this article
Timmis, A., Jones, C. & Paize, F. An unusual DMSA scan: answer. Pediatr Nephrol 27, 225–227 (2012). https://doi.org/10.1007/s00467-011-1914-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-011-1914-x